| 2019 | Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study
| Journal of Thoracic Oncology |
| 2024 | Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer
| LUNG CANCER |
| 2022 | Updated efficacy and safety of entrectinib in patients (pts) with NTRK fusion-positive (NTRK-fp) NSCLC | ANNALS OF ONCOLOGY |
| 2021 | Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer | JOURNAL OF CLINICAL ONCOLOGY |
| 2022 | Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors
| CLINICAL CANCER RESEARCH |
| 2015 | Updated Korean Clinical Practice Guidelines on Decompressive Surgery for Malignant Middle Cerebral Artery Territory Infarction
| JOURNAL OF STROKE |
| 2022 | Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
| CLINICAL CANCER RESEARCH |
| 2021 | Updated recommendations for the treatment of venous thromboembolism
| BLOOD RESEARCH |
| 2018 | Updated treatment strategies for intestinal Behcet's disease
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2023 | Updates in renal pathology
| KIDNEY RESEARCH AND CLINICAL PRACTICE |
| 2020 | Updates in the diagnosis of combined hepatocellular-cholangiocarcinoma | HUMAN PATHOLOGY |
| 2015 | Updates in the Pathogenesis of Rosacea | Journal of Skin Barrier Research (한국피부장벽학회지) |
| 2022 | Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2022 | Updates on the ketogenic diet therapy for pediatric epilepsy
| BIOMEDICAL JOURNAL |
| 2020 | Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphoma | ANNALS OF HEMATOLOGY |
| 2021 | Upfront chemotherapy and short-course radiotherapy with delayed surgery for locally advanced rectal cancer with synchronous liver metastases | EJSO |
| 2019 | Upfront chemotherapy followed by response adaptive radiotherapy for intracranial germinoma: Prospective multicenter cohort study | Radiotherapy and Oncology |
| 2020 | Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial
| TRIALS |
| 2011 | Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases.
| RADIATION ONCOLOGY |
| 2016 | Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors
| PLOS ONE |
